Nine Ann Medical: Suggests Tianjin Adopt Family Self-Testing Box
Nine Ann Medical: Suggests Tianjin Adopt Family Self-Testing Box
Nine Ann Medical suggests that, within the sealing and controlling area, for the families that do not have symptoms, using the self-testing box each person to self-test once a day for five consecutive days of testing, Nine Ann Medical: Suggests Tianjin Adopt Family Self-Testing Box.
新冠自测会不会在国内实行，一直受社会关注。1月10日晚，"大牛股 "九安医疗在互动平台上披露的信息显示，国内新冠自测胎动，天津正在研究 "九安 The first time I saw this, I was able to see the newest version of the "medical version" of the self-testing proposal.
Tianjin is studying the new crown self-testing recommendations
Tianjin is the first to find out the local Omicron variant of the news, in the country has caused a lot of concern.
January 10 held a press conference on the prevention and control of the new coronavirus pneumonia outbreak in Tianjin, Tianjin Municipal Government Deputy Secretary General, Director of the Municipal Health Commission Gu Qing introduced, so far, the current round of the epidemic in Tianjin City, the cumulative total of 31 reported cases of indigenous confirmed cases, asymptomatic infected people 10 cases. Other new initial screening positive infected people to be further verified by the clinical expert group to inform.
As of 15:00 on January 10th, Tianjin has accumulated a total of 1,152 close contacts and 685 secondary close contacts, all of which have been quarantined and controlled. All of the places involved in the epidemic have implemented final disinfection. The current round of epidemic in Tianjin has accumulated about 75,000 people in isolation management.
● For Omicron variant virus, Tianjin listed company - Jiu'an Medical has test reagents, on January 5, 2022, the company received the iHealth New Crown Antigen Home Self-Test OTC kit against Omicron variant virus test performance experimental report. The report showed that the OTC kit detected 100% of Omicron active virus samples with a maximum CT value of 21.59 (n=5) in the experiment.
Meanwhile, in the investor relations activity record sheet disclosed on January 10, in response to a question about the "Deltacron" strain, whether the company has made preparations, JiuAn Medical said the company is paying close attention to the mutant strain, and will carry out bioinformatics comparison as soon as possible, and real-time start recombinant N protein testing as well as testing after obtaining the mutant strain, the company will also carry out a test on the "Deltacron" strain. The company is paying close attention to the mutant strain, and will carry out bioinformatics comparison, real-time start recombinant N protein testing and test performance experiments after obtaining the mutant strain.
It is worth noting that the Securities Times - e company found that in this investor relations activities record sheet, but also revealed an important information - Jiu'an Medical has submitted to the Tianjin Epidemic Prevention and Control Command "on the use of family self-testing box to realize the Omicron Xinguang epidemic prevention 1 +1 proposal".
● Nine Ann Medical said that the Omicron variant virus is highly contagious, and now the number of patients testing positive in both Europe and the United States is rising sharply, and according to the latest article published by the British Human Antivirus Experiment, some patients have the ability to detoxify the virus before the PCR test is able to detect a positive result. In fact, the process of queuing up to brush up on nucleic acids is itself a form of exposure; firstly, the queuing process may extend for hours, and secondly, the safety distance between people in the queue is difficult to strictly control. Based on this, the company has submitted to the Tianjin Epidemic Prevention and Control Command "on the use of family self-testing box to realize the Omicron Xinguang epidemic prevention 1 +1 proposal".
Home self-test kit, also commonly known as the new crown self-test (antigen reagent). Currently, in the way of screening the new crown infected people, the way used in China is the nucleic acid test, while Europe and the United States and other overseas countries are adopting the new crown self-test in large quantities. If Jiuan Medical's self-testing proposal can be adopted, it will mean an important change in the way domestic screening of new crown infected people will take place.
Currently, China's epidemic prevention and control has achieved significant strategic results, which naturally can not be separated from the nucleic acid test behind the credit. However, with the changes in the situation of the new crown epidemic prevention and control, the advantages of self-testing, aggregated outbreaks exposed the shortcomings and weaknesses of prevention and control, as well as to reduce the impact of social activities on economic activities, the adjustment of the new crown detection method of the call is not lacking in supporters.
This investor relations activity sheet also reveals that the relevant departments of Tianjin are studying the above program of Jiu'an Medical. Although it is not known whether it will eventually be adopted, the signal released is worth paying attention to.
Nine Ann Medical: Suggests Tianjin Adopt Home Self-Test Kit2
Nine Ann Medical's new home crown test kit has a new direction.
The evening of January 10, Tianjin Jiuan Medical Electronics Company Limited (Jiuan Medical, 002432) released the media interviews of the investor relations activities record sheet. In response to the media's question, "As a local company in Tianjin, has NineAnn Medical considered selling its kits in China? Or is there any new arrangement in the production line?" JiuAn Medical replied that the company has submitted to the Tianjin Epidemic Prevention and Control Command the "Proposal on the Use of Family Self-Testing Kits to Realize Omicron Xinguang Epidemic Prevention 1+1", and the Tianjin authorities are studying the company's . Program.
Jiuan Medical mentioned in the above proposal, from the British and American Omicron public **** epidemic prevention experience, the use of nucleic acid testing (diagnosis) + family self-testing (screening) can achieve 1 +1>2 effect, can be more effective in blocking the spread of Omicron, is an effective means of controlling the epidemic of the public **** sanitary epidemic prevention.
Jiuan Medical suggests that, in the sealing and control area, for families without symptoms, use the self-measurement box to self-measure once a day per person for 5 consecutive days, and report the results of each measurement through the photo app with the nucleic acid test; in the control area, for families without symptoms, measure once a day per person for 3 consecutive days, and report the results of the measurement through the photo app with the nucleic acid test; and in the precautionary area, for families without symptoms, measure once a day for 3 consecutive days. and other areas, for people and families with cold symptoms, people and families who have had time overlap, to encourage people to measure themselves, the test results photographed App reported.
Jiuan Medical also mentioned that it hopes to put Jiuan Medical's "iHealth New Crown Self-Testing Box" through the Tianjin Municipal Drug Administration's emergency approval, and as soon as possible, put it into the front line of Tianjin's prevention and control of the spread of omikron.
Nine Ann Medical said, the company will be in accordance with the relevant requirements of the national epidemic prevention and control of the company and plant content to do a good job of epidemic prevention and control, and arrange for personnel to do a good job of nucleic acid testing, the company's production and operation is normal. The company will continue to pay close attention to the development of the epidemic, the market situation, and the supply chain, real-time adjustments in production arrangements related matters.
In the investor relations record sheet, nine Ann Medical responded to the "Deltacron" strain problem, said that the mutant strain is being closely watched, and will be carried out as soon as possible on its bioinformatics comparison, real-time recombinant N protein test and after obtaining the mutant strain test performance experiments and other related verification.
Since the end of 2021, due to the news related to the home self-testing new crown antigen detection kit, nine Ann Medical harvested more than 20 stops, and recently the stock price has retreated. on January 11, nine Ann Medical shares rose, as of press time, the stock price of 54.39 yuan, up nearly 6%, the market value of 25.7 billion yuan.
九安医疗：建议天津采用家庭自测盒3Since its launch on November 11, 2021, the bullish stock Jiuan Medical (002432) has risen from 6.38 yuan to the current nearly 60 yuan, just more than two months the stock price doubled nearly ten times. And it is so crazy the main reason is that it produces the iHealth new crown antigen home self-test OTC kit in the United States sold. And what makes the stock price add fuel to the fire is that Jiu'an Medical (002432) to Tianjin proposal: the use of home self-testing kits to realize the Omicron Xinkuan epidemic prevention.
Family self-test box, also known as the new crown self-test (antigen reagent). Currently, there are two main types of tests used around the world, the domestic approach is nucleic acid testing, while Europe and the United States and other overseas countries are adopting a large number of new crown self-testing.
In the United States, home kits are not as accurate as PCR tests performed in hospitals and testing centers. But they have the advantage of getting results in minutes rather than days. Rapid test kits are available at many pharmacies and do not require a prescription. One in five people in the U.S. currently have a confirmed new crown. As the number of new infections soars, more and more Americans are finding it impossible to find a place to get a nucleic acid test, and there are often long lines out the door of those open testing sites. Against this backdrop, the U.S. government announced on January 4 that it will soon sign a contract to purchase 500 million rapid test kits for the new coronavirus, which will be distributed free of charge to those who need them when they arrive.
There are reports that overseas demand for test kits from China has been increasing. Customs data statistics show that in November 2021, China's HS code 30021500 diagnostic reagents (mainly for the new crown antigen reagents) export value reached 4.165 billion yuan, an increase of 80.62% compared with October, for the first time after six consecutive months of decline, the ring growth. Based on the judgment of the future industry trends, it is expected that in 2022, Europe and the United States combined new crown test market size is expected to reach 3.391 billion U.S. dollars, equivalent to about 22 billion yuan.
Currently, China's epidemic prevention and control has achieved significant strategic results, which naturally can not be separated from the nucleic acid test behind the credit. However, with the changes in the situation of the new crown epidemic prevention and control, self-testing advantage of the emergence of the aggregated epidemic exposed prevention and control shortcomings and weaknesses, as well as to reduce the impact of social activities on economic activities, the adjustment of the new crown testing method of appeal has no shortage of supporters. If nine Ann medical (002432) self-testing recommendations can be adopted, will mean that the domestic screening new crown infected people way, will be an important change.
So, in addition to the nine Ann medical (002432), how many companies in the two cities currently have the production of home test kits? According to my statistics, has been recognized in the interactive platform of the real hammer of the company is mainly the following:
Dean Diagnostics (300244) in the investor interactive platform, said the subsidiary Dean Biological R & D and production of the "Golden Dean new crown virus antigen detection kit (COVID-19 Antigen Test Cassette) ", the product can be used for home self-testing, has been sold in Germany, Austria and other European countries.
Yafei Long (688575): The company's self-developed OTC kit for home self-testing of neo-crown antigen has obtained EU CE certification, and can be sold in EU countries and countries that recognize EU CE certification. At present, the company is actively developing the international market related business.
Boto Bio (688767) said in the investor interactive platform, the company's production of new crown antigen home self-testing test reagents have obtained CE certificate, can be exported to the EU.
Shuo Shi Bio (688399): the company's new coronavirus antigen rapid test kit (self-test) has obtained the CE certificate of the European Union.
Corfu medical (301087) in the Shenzhen Stock Exchange "interactive easy" platform to answer investor questions, said that the company's home self-testing new coronavirus testing product qualification related reporting procedures are being promoted, the company will actively cooperate with the review work, and strive to make the product listed as soon as possible.
LPMC (300003): The company's new crown antigen self-testing kit has been awarded the European Union's CE certification, the European DOC and Germany's home test registration certificate.
Kemper Bio (300639): said the company has been on the new crown nucleic acid rapid test kit for the project, on the progress of this matter please pay attention to the company's announcement.
Wanfu Biological (300482) the company's new coronavirus antigen self-detection reagent can be collected by individuals themselves before the nasal swab samples for operation, 15 minutes fast results, convenient for individuals and families to carry out rapid detection of the new coronavirus, can better meet the needs of the countries of the epidemic home detection and prevention and control, and further enriched the Wanfu Biological full scenarios of the new crown detection solutions.
Oriental Bio (688298): It has been reported that the UK has implemented home testing for New Crown, and Oriental Bio's reagents have been shipped for export.
Thermal View Bio (688068) The company's new coronavirus antigen detection kit was earlier certified by the German Federal Institute for Drugs and Medical Devices (BfArM) for use in home free testing, and is available for sale in German superstores, drugstores, and internet stores.